27.04.2017
- Bioelectronic technologies for modulating the signaling capabilities of the nervous system could pose challenges for producers of medicinal materials and chemicals – but also for...
02.08.2016
- UK drugmaker Glaxo SmithKline (GSK) is teaming up with Verily Life Sciences (formerly Google Life Sciences) to create a new company focused on developing bioelectronic medicines...
09.08.2013
- GlaxoSmithKline raised its bet on using electrical signals in the body to target diseases on Thursday with the launch of a $50 million strategic venture capital fund. Britain's...
10.04.2013
- GlaxoSmithKline, Britain's biggest drugmaker, is placing a small but important bet on a new way of treating diseases by targeting electrical signals in the body. The company said...
